PRLAX
Price
$23.83
Change
+$0.19 (+0.80%)
Updated
Jun 26 closing price
Net Assets
456.26M
VPADX
Price
$141.78
Change
-$1.61 (-1.12%)
Updated
Jun 26 closing price
Net Assets
13.83B
Interact to see
Advertisement

PRLAX vs VPADX

PRLAX vs VPADX Comparison Chart in %
View a ticker or compare two or three
VS
PRLAX vs. VPADX commentary
Jun 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRLAX is a Buy and VPADX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VPADX has more cash in the bank: 13.8B vs. PRLAX (456M). PRLAX (2.87) and VPADX (2.75) have matching dividends . PRLAX was incepted earlier than VPADX: PRLAX (33 years) vs VPADX (25 years). PRLAX (1.51) is less costly to investors than VPADX (0.09). PRLAX is a more actively managed with annual turnover of: 34.20 vs. VPADX (7.00). PRLAX has a lower initial minimum investment than VPADX: PRLAX (2500) vs VPADX (3000). VPADX annual gain was more profitable for investors over the last year : 41.26 vs. PRLAX (19.15). VPADX return over 5 years is better than : 42.10 vs. PRLAX (13.98).
PRLAXVPADXPRLAX / VPADX
Total Expense Ratio1.470.091,633%
Annual Report Gross Expense Ratio1.510.091,678%
Fund Existence33 years25 years-
Gain YTD7.77926.47629%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets456M13.8B3%
Annual Yield % from dividends2.872.75105%
Returns for 1 year19.1541.2646%
Returns for 3 years22.8869.3333%
Returns for 5 years13.9842.1033%
Returns for 10 years58.14122.4547%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACON2.850.14
+5.17%
Aclarion Inc
BALY14.980.52
+3.60%
Bally's Corporation
RPRX56.231.54
+2.82%
Royalty Pharma plc
OGN13.500.03
+0.22%
Organon & Co
BRR1.42-0.03
-2.07%
Columbus Circle Capital Corp I